Search Results 1211-1220 of 16182 for Epilepsy (Partial Onset)

  1. A Study to Evaluate Outpatient Blinatumomab in Subjects with Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL) - Mayo Clinic

    Subject resides within 1 hour of ground transportation to an advanced medical care facility for the duration of the MDMP. ... seizure, paresis, aphasia ...

  2. A Study to Evaluate Caregiver Connections via Technology for Patients with Alzheimer's and Other Types of Dementia - Mayo Clinic

    ... partial assistance with daily activities at least 3 days per week. The ... All participants must agree to follow-up contact throughout the duration of the study, ...

  3. Biorepository for Acute Leukemia Research - Mayo Clinic

    These activities are a first step toward identifying alternative therapies and subsequently beginning to personalize the therapy for these disorders.

  4. Health Topics - Mayo Clinic News Network

    'Dogtor' and doctor return joy to boy with severe epilepsy. Susan Barber Lindquist. November 15, 2023. Featured News. Mayo Clinic hospital recognized for ...

  5. Diseases and Conditions - Clinical Trials

    Diseases and conditions · Abdominal aortic aneurysm · Absence seizure · Achalasia · Achilles tendinitis · Achilles tendon rupture · ACL injury · Acne · Acoustic neuroma ...

  6. Prasugrel (oral route) - Mayo Clinic

    ... seizures, weakness, yellow eyes or skin. These may be symptoms of a serious condition called thrombotic thrombocytopenic purpura (TTP). This medicine may ...

  7. Multiple Sclerosis Clinical Trials - Mayo Clinic Research

    ... onset MS. A Study of the Safety and Use of Tecfidera in Routine Medical ... onset multiple sclerosis (POMS) patients/family participation in research ...

  8. Pseudoephedrine (oral route) - Mayo Clinic

    Convulsions (seizures); hallucinations (seeing, hearing, or feeling things ... shortness of breath or troubled breathing. Symptoms of overdose. Convulsions ( ...

  9. Spinal cord tumor - Doctors and departments - Mayo Clinic

    Richard Marsh, M.D.. Neurosurgeon. Rochester, MN. Areas of focus: Epilepsy surgery, Brain tumor surgery, Trigeminal neuralgia surgery, Chiari malformation ...

  10. ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer - Mayo Clinic

    ≥2 weeks from discontinuation of anti-seizure medication. ... Declaration of abstinence for the duration of exposure to study treatment and withdrawal are not ...